Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 16 min 52 sec ago

Spectrum Pharmaceuticals Divests Rights to ZEVALIN(R) (ibritumomab tiuxetan) in Japan and Select Other Ex-US Countries to Mundipharma

Wed, 11/18/2015 - 13:09
Spectrum to receive an up-front payment of $15 million plus $5 million in profits on initial ZEVALIN supply HENDERSON, Nev.--(Healthcare Sales & Marketing Network)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated...
Biopharmaceuticals
Spectrum Pharmaceuticals, ZEVALIN, Mundipharma

Amethyst Radiotherapy Orders Elekta Cancer Treatment Solutions for European Expansion

Wed, 11/18/2015 - 13:02
High-end linear accelerators to be delivered to clinics in France, Poland and Romania STOCKHOLM, November 18, 2015 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) will deliver advanced radiotherapy equipment and services to Amethyst Rad...
Devices, Oncology
Elekta, radiotherapy, linear accelerator, Versa HD, Elekta Infinity

Cook Medical Launches EchoTip ProCore(R) 20 Gage Needle

Tue, 11/17/2015 - 15:37
BLOOMINGTON, Ind.--(Healthcare Sales & Marketing Network)--Cook Medical’s Endoscopy clinical division announces the introduction of the latest addition to the EchoTip ProCore® product line, the EchoTip ProCore 20 gage needle with ReCoil Stylet™. This n...
Devices, Product Launch
Cook Medical, EchoTip, ProCore, biopsy

Mylan Launches Generic AXERT(R) Tablets

Tue, 11/17/2015 - 15:34
HERTFORDSHIRE, England and PITTSBURGH, Nov. 17, 2015 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Almotriptan Tablets USP, 6.25 mg and 12.5 mg, the generic version of Janssen Pharmaceutical...
Biopharmaceuticals, Generics, Product Launch
Mylan, AXERT, Almotriptan, migraine

Pharma Industry Veterans Launch Vertice Pharma in Partnership with Warburg Pincus; Announce Acquisition of VistaPharm

Tue, 11/17/2015 - 15:31
Warburg Pincus to Invest up to $300 Million to Build Leading Specialty Pharmaceuticals Platform NEW YORK, Nov. 17, 2015 -- (Healthcare Sales & Marketing Network) -- Pharmaceutical industry veterans Don DeGolyer and Andrew Saik today announced that they...
Biopharmaceuticals, Mergers & Acquisitions
Vertice Pharma, VistaPharm

KFx Announces Win at United States Supreme Court

Tue, 11/17/2015 - 15:28
SAN DIEGO--(Healthcare Sales & Marketing Network)--KFx Medical announced that a petition for writ of certiorari filed by Arthrex was denied by the Supreme Court of the United States. The Supreme Court refused Arthrex’s request for review of a patent infrin...
Devices, Orthopaedic, Litigation
KFx Medical, Arthrex

Profound Medical Corp. Announces Departure of CFO

Tue, 11/17/2015 - 15:23
TORONTO, Nov. 17, 2015 -- (Healthcare Sales & Marketing Network) -- Profound Medical Corp. ("Profound" or the "Company") (PRN.V) today announced that Mr. Shameze Rampertab has tendered his resignation as Chief Financial Officer of the C...
Devices, Oncology, Urology, Personnel
Profound Medical, transurethral therapeutic ultrasound, prostate cancer

ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences

Tue, 11/17/2015 - 15:17
Company Secures $80+ Million in Committed Funding to Develop Exosome-Based Therapeutic and Diagnostic Products Douglas E. Williams, Ph.D., Named President and Chief Executive Officer CAMBRIDGE, Mass. and HOUSTON, Nov. 17, 2015 -- (Healthcare Sales & ...
Biopharmaceuticals, Oncology, Venture Capital, Personnel
Codiak BioSciences, exosomes

Vigilant Biosciences Announces Distribution Agreements for OncAlert(TM) Oral Cancer System for Czech Republic and Slovakia, Israel and Baltic Region

Tue, 11/17/2015 - 15:11
FORT LAUDERDALE, Fla., Nov. 17, 2015 -- (Healthcare Sales & Marketing Network) -- Vigilant Biosciences, Inc., a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today three exclusive multi...
Diagnostics, Oncology, Distribution
Vigilant Biosciences, OncAlert, Oral Cancer

CONMED Announces Definitive Agreement to Acquire SurgiQuest, Inc.

Mon, 11/16/2015 - 13:22
Significantly bolsters CONMED’s Advanced Surgical portfolio CONMED to host conference call today at 8:00 a.m. ET UTICA, N.Y.--(Healthcare Sales & Marketing Network)--CONMED Corporation (CNMD) today announced a definitive agreement to acquire privatel...
Devices, Surgery, Mergers & Acquisitions
CONMED Corp, SurgiQuest, AirSeal

NeuroSigma's Monarch eTNS System Receives CE Mark Approval for ADHD

Mon, 11/16/2015 - 13:14
Treatment of Attention-Deficit/Hyperactivity Disorder with Non-Invasive External Trigeminal Nerve Stimulation LOS ANGELES, Nov. 16, 2015 -- (Healthcare Sales & Marketing Network) -- NeuroSigma®, Inc. (NeuroSigma) today announced that it has receive...
Devices, Neurology, Regulatory
NeuroSigma, Monarch eTNS System, ADHD, External Trigeminal Nerve Stimulation

Vigilant Biosciences Receives CE Mark for OncAlert(TM) Oral Cancer CD44/Total Protein LAB Test to Aid in Diagnosis of Oral Cancer

Mon, 11/16/2015 - 13:08
First and Only Test to Detect a Tumor-initiating Stem Cell Biomarker for Head and Neck Cancer FORT LAUDERDALE, Fla., Nov. 16, 2015 -- (Healthcare Sales & Marketing Network) -- Vigilant Biosciences, Inc., a leading innovator and developer of solutions ...
Diagnostic, Oncology, Regulatory
Vigilant Biosciences, OncAlert LAB Assay, oral cancer

First US Commercial Appointment: Atlas Genetics Appoints Keith Stauffer as VP Sales and Marketing

Mon, 11/16/2015 - 13:01
BATH, England, November 16, 2015 -- (Healthcare Sales & Marketing Network) -- Atlas Genetics Ltd ("Atlas Genetics" or the "Company"), the ultra-rapid Point-Of-Care (POC) molecular diagnostics company, today announces the appointment of...
Diagnostics, Personnel
Atlas Genetics, io System, Alere i

AbbVie Submits IMBRUVICA(R) (ibrutinib) Phase III Combination Data to U.S. FDA

Fri, 11/13/2015 - 15:13
Phase III HELIOS (CLL3001) trial assessed the safety and efficacy of IMBRUVICA plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma NORTH CHICAGO, Ill., Nov. 13, 2015 -- (Healthc...
Biopharmaceuticals, Oncology, FDA
AbbVie, IMBRUVICA, ibrutinib, chronic lymphocytic leukemia

Merck Provides Update on REVEAL Outcomes Study

Fri, 11/13/2015 - 15:09
KENILWORTH, N.J.--(Healthcare Sales & Marketing Network)--Merck (MRK), known as MSD outside the United States and Canada, today announced that the Data Monitoring Committee (DMC) of the REVEAL outcomes study for anacetrapib has completed its planned review...
Biopharmaceuticals, Cardiology
Merck, anacetrapib, hypercholesterolemia

RetroSense Therapeutics Raises $6 million in an Over-Subscribed Series B Financing to Advance Clinical Development of Lead Product RST-001 for Retinitis Pigmentosa

Thu, 11/12/2015 - 18:55
Patient recruitment underway for Phase I/II clinical study ANN ARBOR, Mich.--(Healthcare Sales & Marketing Network)--RetroSense Therapeutics, a privately-held, clinical-stage biopharmaceutical company, today announced that it has secured $6 million in a...
Biopharmaceuticals, Ophthalmology, Venture Capital
RetroSense Therapeutics, optogenetics, Retinitis Pigmentosa

Viamet Appoints Dr. Volker Herrmann as Chief Commercial Officer

Thu, 11/12/2015 - 18:48
RESEARCH TRIANGLE PARK, N.C.--(Healthcare Sales & Marketing Network)--Viamet Pharmaceuticals, Inc. today announced the appointment of Volker Herrmann, M.D., M.B.A., as Chief Commercial Officer. Dr. Hermann is an accomplished pharmaceutical executive with e...
Biopharmaceuticals, Personnel
Viamet Pharmaceuticals, metalloenzyme

Rosetta Provides Update on Performance Data and Launch of RosettaGX Reveal(TM) (Thyroid microRNA Classifier)

Thu, 11/12/2015 - 15:45
Sensitivity and Negative Predictive Value in key Sub-Classes Establishes New Standard in Industry Beginning to Receive and Process Commercial Samples PHILADELPHIA & REHOVOT, Israel--(Healthcare Sales & Marketing Network)--Rosetta Genomics Ltd. (ROSG...
Diagnostics, Personalized Medicine, Oncology
Rosetta Genomics, RosettaGX Reveal, thyroid cancer

IntraOp Completes Delivery of IntraOp(R) Mobetron(R) Electron IORT System to Nanjing General Hospital

Thu, 11/12/2015 - 15:42
From treating breast to pancreatic, to colorectal, and beyond, Mobetron continues to be the leading IORT technology in China with it first installation in the Jiangsu Province SUNNYVALE, Calif., Nov. 12, 2015 -- (Healthcare Sales & Marketing Network) -...
Devices, Oncology, Surgery
IntraOp Medical, Mobetron, intraoperative radiation therapy, radiotherapy

In New Study EMMA(TM) Capnograph Has Comparable Accuracy to Sidestream Capnography Against Gold-Standard Blood Gas Analysis

Thu, 11/12/2015 - 15:36
IRVINE, Calif.--(Healthcare Sales & Marketing Network)--Masimo (MASI) announced today that in a new study that compared the end tidal carbon dioxide values (EtCO2) from both the Masimo EMMA capnograph and a conventional sidestream capnography device to the...
Devices, Monitoring
Masimo, EMMA capnograph, capnography, blood gas, carbon dioxide

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong